Relative survival of patients with supratentorial low-grade gliomas

Neuro-Oncology

Volumn 14, Issue 8, 2012, Pages 1062-1069

  Smoll, Nicolas R ^a,b   Gautschi, Oliver P ^a   Schatlo, Bawarjan ^a   Schaller, Karl ^a   Weber, Damien C ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF BALLARAT   (Australia)

Author keywords

age standardized survival; brain tumor; low grade glioma; relative survival; standardized mortality ratio

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; FEMALE; FOLLOW UP; GLIOMA; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; STATISTICAL MODEL; SUPRATENTORIAL LOW GRADE GLIOMA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; FEMALE; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; SEER PROGRAM; SUPRATENTORIAL NEOPLASMS; YOUNG ADULT;

EID: 84864703360     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos144     Document Type: Article

References (29)

1. CBTRUS. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007. 2011. Accessed February 25, 2012.
2. Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005;109(1):93-108.
3. Houben MP, Aben KK, Teepen JL, et al. Stable incidence of childhood and adult glioma in The Netherlands, 1989-2003. Acta oncologica. 2006;45(3):272-279.
4. van den Bent MJ, Afra D, de Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial. Lancet. 2005;366(9490):985-990.
5. Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: Data from the SEER program, 1973-2001. Cancer. 2006;106(6):1358-1363.
6. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: An interim analysis. International Journal of Radiation Oncology, Biology, Physics. 2002;52(2):316-324.
7. KarimAB,Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. International Journal of Radiation Oncology, Biology, Physics. 1996;36(3):549-556.
8. Surveillance, Epidemiology and End Results (SEER) Program. SEER 17 Regs Research Data 1973-2007. In: National Cancer Institute D, Surveillance Research Program, Cancer Statistics Branch, ed. 2011.
9. Surveillance, Epidemiology and End Results (SEER) Program. SEER*Stat Database: Mortality - All COD, aggregated with state, Total U.S. (1969- 2006), Underlying mortality data provided by NCHS (http://www.cdc.gov/nchs). In: National Cancer InstituteD, SurveillanceResearch Program,Cancer Statistics Branch, ed 2010.
10. Brenner H, Gefeller O. An alternative approach to monitoring cancer patient survival. Cancer. 1996;78(9):2004-2010.
11. Albritton K, Caligiurim M, Anderson B, Nichols C, Ulman D. Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer. Report of the Adolescent and Young Adult Oncology Progress Review Group. 2006: 108.
12. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med. 2004;23(1):51-64.
13. Hakulinen T, Seppa K, Lambert PC. Choosing the relative survival method for cancer survival estimation. Eur J Cancer. 2011;47(14):2202-2210.
14. Kaloshi G, Psimaras D, Mokhtari K, et al. Supratentorial low-grade gliomas in older patients. Neurology. 2009;73(24):2093-2098.
15. Korshunov A, Remke M,WerftW, et al. Adult and pediatricmedulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. J Clin Oncol. 2010;28(18):3054-3060.
16. Parsons DW, Li M, Zhang X, et al. The Genetic Landscape of the Childhood Cancer Medulloblastoma. Science. 2010;331(6016): 435-439.
17. Broniscer A, Baker SJ, West AN, et al. Clinical and molecular characteristics of malignant transformation of low-grade glioma in children. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2007;25(6):682-689.
18. Felix CA, Slavc I, Dunn M, et al. p53 gene mutations in pediatric brain tumors. Med Pediatr Oncol. 1995;25(6):431-436.
19. Walker C, Haylock B, Husband D, et al. Clinical use of genotype to predict chemosensitivity in oligodendroglial tumors. Neurology. 2006;66(11):1661-1667.
20. Walker C, Haylock B, Husband D, et al. Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms. Br J Cancer. 2006;95(10):1424-1431.
21. Mariani L, Deiana G, Vassella E, et al. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2006;24(29):4758-4763.
22. Varela M, Ranuncolo SM, Morand A, et al. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. J Surg Oncol. 2004;86(1):34-40.
23. Nakamura M, Shimada K, Ishida E, et al. Molecular pathogenesis of pediatric astrocytic tumors. Neuro Oncol. 2007;9(2):113-123.
24. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2002;20(8):2076-2084.
25. Smoll NR. Relative survival of childhood and adult medulloblastomas and primitive neuroectodermal tumors (PNETs). Cancer. 2012;118(5):1313-1322.
26. Sutton LN, Cnaan A, Klatt L, et al. Postoperative surveillance imaging in children with cerebellar astrocytomas. Journal of Neurosurgery. 1996;84(5):721-725.
27. Torres CF, Rebsamen S, Silber JH, et al. Surveillance scanning of children with medulloblastoma. N Engl J Med. 1994;330(13):892-895.
28. Vassilyadi M, Shamji MF, Tataryn Z, Keene D, Ventureyra E. Postoperative surveillance magnetic resonance imaging for cerebellar astrocytoma. Can J Neurol Sci. 2009;36(6):707-712.
29. Kun LE, D'Souza B, Tefft M. The value of surveillance testing in childhood brain tumors. Cancer. 1985;56(7 Suppl):1818-1823.